• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

嘧啶 2,4-二酮类在新型 HIV RT 抑制剂设计中的应用。

Pyrimidine 2,4-Diones in the Design of New HIV RT Inhibitors.

机构信息

Dipartimento di Scienze chimiche, biologiche, farmaceutiche ed ambientali, Università di Messina, Via S.S. Annunziata, 98168 Messina, Italy.

Dipartimento di Ingegneria, Università di Messina, Contrada Di Dio, 98166 Messina, Italy.

出版信息

Molecules. 2019 May 2;24(9):1718. doi: 10.3390/molecules24091718.

DOI:10.3390/molecules24091718
PMID:31052607
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6539630/
Abstract

The pyrimidine nucleus is a versatile core in the development of antiretroviral agents. On this basis, a series of pyrimidine-2,4-diones linked to an isoxazolidine nucleus have been synthesized and tested as nucleoside analogs, endowed with potential anti-HIV (human immunodeficiency virus) activity. Compounds -, characterized by the presence of an ethereal group at C-3, show HIV reverse transcriptase (RT) inhibitor activity in the nanomolar range as well as HIV-infection inhibitor activity in the low micromolar with no toxicity. In the same context, compound shows only a negligible inhibition of RT HIV.

摘要

嘧啶核是开发抗逆转录病毒药物的多功能核心。在此基础上,合成了一系列连接异噁唑烷核的嘧啶-2,4-二酮,并将其作为核苷类似物进行了测试,具有潜在的抗 HIV(人类免疫缺陷病毒)活性。化合物 - ,其特征在于在 C-3 处具有醚基团,在纳摩尔范围内表现出 HIV 逆转录酶 (RT) 抑制剂活性,并且在低微摩尔范围内具有 HIV 感染抑制剂活性,而没有毒性。在相同的背景下,化合物 仅对 HIV RT 表现出可忽略的抑制作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e3a/6539630/8793142ae685/molecules-24-01718-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e3a/6539630/6c37970dc8b1/molecules-24-01718-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e3a/6539630/a1a19f67ca4a/molecules-24-01718-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e3a/6539630/0a0be6a80e85/molecules-24-01718-sch001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e3a/6539630/2be40b3c8b58/molecules-24-01718-sch002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e3a/6539630/42218a3b71a9/molecules-24-01718-sch003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e3a/6539630/61b1abab2c47/molecules-24-01718-sch004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e3a/6539630/8793142ae685/molecules-24-01718-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e3a/6539630/6c37970dc8b1/molecules-24-01718-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e3a/6539630/a1a19f67ca4a/molecules-24-01718-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e3a/6539630/0a0be6a80e85/molecules-24-01718-sch001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e3a/6539630/2be40b3c8b58/molecules-24-01718-sch002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e3a/6539630/42218a3b71a9/molecules-24-01718-sch003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e3a/6539630/61b1abab2c47/molecules-24-01718-sch004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e3a/6539630/8793142ae685/molecules-24-01718-g003.jpg

相似文献

1
Pyrimidine 2,4-Diones in the Design of New HIV RT Inhibitors.嘧啶 2,4-二酮类在新型 HIV RT 抑制剂设计中的应用。
Molecules. 2019 May 2;24(9):1718. doi: 10.3390/molecules24091718.
2
6-Benzoyl-3-hydroxypyrimidine-2,4-diones as dual inhibitors of HIV reverse transcriptase and integrase.6-苯甲酰基-3-羟基嘧啶-2,4-二酮作为 HIV 逆转录酶和整合酶的双重抑制剂。
Bioorg Med Chem Lett. 2011 Apr 15;21(8):2400-2. doi: 10.1016/j.bmcl.2011.02.069. Epub 2011 Feb 18.
3
Structure-based design, synthesis, and biological evaluation of conformationally restricted novel 2-alkylthio-6-[1-(2,6-difluorophenyl)alkyl]-3,4-dihydro-5-alkylpyrimidin-4(3H)-ones as non-nucleoside inhibitors of HIV-1 reverse transcriptase.基于结构的新型2-烷硫基-6-[1-(2,6-二氟苯基)烷基]-3,4-二氢-5-烷基嘧啶-4(3H)-酮的设计、合成及生物学评价,该化合物为HIV-1逆转录酶的非核苷抑制剂
J Med Chem. 2001 Aug 2;44(16):2544-54. doi: 10.1021/jm010853h.
4
Molecular design, synthesis and biological evaluation of BP-O-DAPY and O-DAPY derivatives as non-nucleoside HIV-1 reverse transcriptase inhibitors.BP-O-DAPY 和 O-DAPY 衍生物作为非核苷 HIV-1 逆转录酶抑制剂的分子设计、合成与生物评价。
Eur J Med Chem. 2013 Jul;65:134-43. doi: 10.1016/j.ejmech.2013.04.052. Epub 2013 May 3.
5
Synthesis and anti-human immunodeficiency virus activity of substituted ( o,o-difluorophenyl)-linked-pyrimidines as potent non-nucleoside reverse transcriptase inhibitors.作为高效非核苷类逆转录酶抑制剂的取代(邻,邻-二氟苯基)连接嘧啶的合成及抗人免疫缺陷病毒活性
Antivir Chem Chemother. 2019 Jan-Dec;27:2040206619826265. doi: 10.1177/2040206619826265.
6
Novel (2,6-difluorophenyl)(2-(phenylamino)pyrimidin-4-yl)methanones with restricted conformation as potent non-nucleoside reverse transcriptase inhibitors against HIV-1.新型(2,6-二氟苯基)(2-(苯氨基)嘧啶-4-基)甲酮具有受限构象,作为有效的非核苷逆转录酶抑制剂,对抗 HIV-1。
Eur J Med Chem. 2016 Oct 21;122:185-195. doi: 10.1016/j.ejmech.2016.06.026. Epub 2016 Jun 17.
7
Design, synthesis, and antiviral evaluation of novel hydrazone-substituted thiophene[3,2-d]pyrimidine derivatives as potent human immunodeficiency virus-1 inhibitors.新型腙取代噻吩[3,2-d]嘧啶衍生物的设计、合成及抗人类免疫缺陷病毒-1 活性评价。
Chem Biol Drug Des. 2018 Dec;92(6):2009-2021. doi: 10.1111/cbdd.13373. Epub 2018 Aug 26.
8
Design and synthesis of a new series of cyclopropylamino-linking diarylpyrimidines as HIV non-nucleoside reverse transcriptase inhibitors.新型环丙基氨基连接二芳基嘧啶系列作为HIV非核苷类逆转录酶抑制剂的设计与合成
Eur J Pharm Sci. 2014 Oct 1;62:334-41. doi: 10.1016/j.ejps.2014.06.003. Epub 2014 Jun 20.
9
Molecular modeling, synthesis and biological evaluation of N-heteroaryl compounds as reverse transcriptase inhibitors against HIV-1.作为抗HIV-1逆转录酶抑制剂的N-杂芳基化合物的分子建模、合成及生物学评价
Chem Biol Drug Des. 2015 Mar;85(3):336-47. doi: 10.1111/cbdd.12397. Epub 2014 Aug 22.
10
Design and synthesis of a new series of modified CH-diarylpyrimidines as drug-resistant HIV non-nucleoside reverse transcriptase inhibitors.新型修饰的CH-二芳基嘧啶系列作为耐药性HIV非核苷逆转录酶抑制剂的设计与合成
Eur J Med Chem. 2014 Jul 23;82:600-11. doi: 10.1016/j.ejmech.2014.05.059. Epub 2014 Jun 5.

引用本文的文献

1
New 3-(Dibenzyloxyphosphoryl)isoxazolidine Conjugates of N1-Benzylated Quinazoline-2,4-diones as Potential Cytotoxic Agents against Cancer Cell Lines.新型 3-(二苄氧基膦酰基)异噁唑烷与 N1-苄基喹唑啉-2,4-二酮的偶联物作为潜在的抗癌细胞系细胞毒剂。
Molecules. 2024 Jun 27;29(13):3050. doi: 10.3390/molecules29133050.
2
Design, synthesis and biological evaluation of novel morpholinopyrimidine-5-carbonitrile derivatives as dual PI3K/mTOR inhibitors.新型吗啉代嘧啶-5-腈衍生物作为双靶点PI3K/mTOR抑制剂的设计、合成及生物学评价
RSC Med Chem. 2024 Feb 2;15(2):733-752. doi: 10.1039/d3md00693j. eCollection 2024 Feb 21.
3
Bioinspired Pyrano[2,3-]chromen-8-ones: Ring C-Opened Analogues of Calanolide A: Synthesis and Anti-HIV-1 Evaluation.

本文引用的文献

1
Novel isoxazolidine analogues of homonucleosides and homonucleotides.同核苷和同核苷酸的新型异恶唑烷类似物。
Tetrahedron. 2016 Dec 15;72(50):8294-8308. doi: 10.1016/j.tet.2016.10.073. Epub 2016 Nov 2.
2
Focus on recently developed assays for detection of resistance/sensitivity to reverse transcriptase inhibitors.关注最近开发的用于检测逆转录酶抑制剂耐药/敏感性的检测方法。
Appl Microbiol Biotechnol. 2018 Dec;102(23):9925-9936. doi: 10.1007/s00253-018-9390-x. Epub 2018 Sep 29.
3
Early Treatment of Primary HIV Infection Is Associated with Decreased Mortality.
受生物启发的吡喃并[2,3 - ]色烯 - 8 - 酮:卡拉诺利德A的C环开环类似物:合成及抗HIV - 1活性评价
Biomimetics (Basel). 2024 Jan 11;9(1):44. doi: 10.3390/biomimetics9010044.
4
Recent medicinal approaches of novel pyrimidine analogs: A review.新型嘧啶类似物的近期医学研究方法:综述
Heliyon. 2023 Jun 2;9(6):e16773. doi: 10.1016/j.heliyon.2023.e16773. eCollection 2023 Jun.
5
Uracil derivatives as HIV-1 capsid protein inhibitors: design, , and cytotoxicity studies.尿嘧啶衍生物作为HIV-1衣壳蛋白抑制剂:设计、 及细胞毒性研究。 (原文中两个逗号之间似乎有缺失内容)
RSC Adv. 2022 Jun 13;12(27):17466-17480. doi: 10.1039/d2ra02450k. eCollection 2022 Jun 7.
6
Multisubstituted pyrimidines effectively inhibit bacterial growth and biofilm formation of Staphylococcus aureus.多取代嘧啶能有效抑制金黄色葡萄球菌的生长和生物膜形成。
Sci Rep. 2021 Apr 12;11(1):7931. doi: 10.1038/s41598-021-86852-5.
7
Design, Synthesis, Molecular Modeling and Antitumor Evaluation of Novel Indolyl-Pyrimidine Derivatives with EGFR Inhibitory Activity.新型具有 EGFR 抑制活性的吲哚基嘧啶衍生物的设计、合成、分子模拟及抗肿瘤活性评价。
Molecules. 2021 Mar 25;26(7):1838. doi: 10.3390/molecules26071838.
8
Synthesis and molecular docking studies of quinoline derivatives as HIV non-nucleoside reverse transcriptase inhibitors.喹啉衍生物作为HIV非核苷逆转录酶抑制剂的合成及分子对接研究
Turk J Chem. 2020 Dec 16;44(6):1623-1641. doi: 10.3906/kim-2004-14. eCollection 2020.
9
Synthesis of Novel 2-(Pyridin-2-yl) Pyrimidine Derivatives and Study of Their Anti-Fibrosis Activity.新型 2-(吡啶-2-基)嘧啶衍生物的合成及其抗纤维化活性研究。
Molecules. 2020 Nov 10;25(22):5226. doi: 10.3390/molecules25225226.
原发性HIV感染的早期治疗与死亡率降低相关。
AIDS Res Hum Retroviruses. 2018 Nov;34(11):936-941. doi: 10.1089/AID.2017.0284. Epub 2018 Jul 17.
4
A Structural View on Medicinal Chemistry Strategies against Drug Resistance.关于抗耐药性药物化学策略的结构观点。
Angew Chem Int Ed Engl. 2019 Mar 11;58(11):3300-3345. doi: 10.1002/anie.201802416. Epub 2019 Jan 14.
5
HIV Drug Resistance - An Emerging Threat to Epidemic Control.艾滋病毒耐药性——对疫情防控的新威胁。
N Engl J Med. 2017 Oct 26;377(17):1605-1607. doi: 10.1056/NEJMp1710608.
6
Thymosin alpha 1 and HIV-1: recent advances and future perspectives.胸腺肽α1与HIV-1:最新进展与未来展望
Future Microbiol. 2017 Feb;12:141-155. doi: 10.2217/fmb-2016-0125. Epub 2017 Jan 20.
7
Discovery of novel piperidine-substituted indolylarylsulfones as potent HIV NNRTIs via structure-guided scaffold morphing and fragment rearrangement.通过结构导向的支架变形和片段重排发现新型哌啶取代的吲哚基芳基砜作为有效的HIV非核苷逆转录酶抑制剂
Eur J Med Chem. 2017 Jan 27;126:190-201. doi: 10.1016/j.ejmech.2016.10.009. Epub 2016 Oct 5.
8
Neurologic Complications in Treated HIV-1 Infection.治疗后 HIV-1 感染的神经并发症。
Curr Neurol Neurosci Rep. 2016 Jul;16(7):62. doi: 10.1007/s11910-016-0666-1.
9
What happens to cardiovascular system behind the undetectable level of HIV viremia?在无法检测到HIV病毒血症水平的情况下,心血管系统会发生什么?
AIDS Res Ther. 2016 Apr 27;13:21. doi: 10.1186/s12981-016-0105-z. eCollection 2016.
10
Testing anti-HIV activity of antiretroviral agents in vitro using flow cytometry analysis of CEM-GFP cells infected with transfection-derived HIV-1 NL4-3.采用流式细胞术分析感染转染衍生 HIV-1 NL4-3 的 CEM-GFP 细胞,检测抗逆转录病毒药物的抗 HIV 活性。
J Med Virol. 2016 Jun;88(6):979-86. doi: 10.1002/jmv.24418. Epub 2015 Nov 9.